Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Insulin Delivery Devices Market be in 2030 compared with 2026?

The insulin delivery devices market has experienced significant expansion in recent years. This market is projected to grow from $19.07 billion in 2025 to $20.61 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.1%. The growth observed in previous periods can be attributed to factors such as the increasing prevalence of diabetes, heightened awareness surrounding diabetes management, improved availability of insulin therapies, wider access to healthcare, and the increasing adoption of self-injection methods.

The insulin delivery devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $28.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This projected increase can be ascribed to several factors, such as an expanding global diabetic population, a heightened need for user-friendly insulin administration techniques, a greater emphasis on sustained diabetes care, improved availability of diabetes treatment in developing economies, and the broader embrace of at-home medical care options. Key developments expected during this timeframe encompass a shift towards insulin pens instead of conventional syringes, an increasing requirement for insulin pumps for ongoing insulin administration, a stronger inclination towards easy-to-use and portable insulin apparatus, the expansion of diabetes management strategies tailored for home environments, and an uptick in the utilization of single-use and pre-filled insulin delivery devices.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Drivers Are Guiding Growth Patterns In The Insulin Delivery Devices Market?

The increasing incidence of diabetes is anticipated to drive expansion within the insulin delivery devices market in the future. Diabetes is a chronic ailment characterized by elevated blood sugar levels, resulting from insufficient insulin secretion by the pancreas or the body’s incapacity to properly use insulin. The rise in diabetes cases is predominantly linked to factors like inactive lifestyles, poor dietary habits, and a global increase in obesity. For individuals with diabetes, insulin delivery devices are essential tools that enable effective management of blood sugar by providing insulin in a controlled and convenient way, thus averting complications and fostering overall well-being. As an illustration, the International Diabetes Federation, a Belgium-based non-governmental organization, reported that in 2024, approximately 589 million adults aged 20–79 globally are afflicted with diabetes. This figure is forecast to escalate to 853 million by 2050. Consequently, the expanding prevalence of diabetes is fueling the growth of the insulin delivery devices market.

Which Segments Are Driving Activity In The Insulin Delivery Devices Market?

The insulin delivery devices market covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

What Trends Are Reshaping The Dynamics Of The Insulin Delivery Devices Market?

Leading firms within the insulin delivery devices sector are creating advanced products, such as insulin pumps, to offer uninterrupted or tailored insulin administration. Insulin pumps are programmable medical instruments designed to deliver insulin continuously or on demand through a subcutaneous catheter. As an illustration, in May 2023, Beta Bionics, a US-based medical technology company, declared the U.S. Food and Drug Administration’s endorsement for its iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is engineered for individuals aged six and above who have type 1 diabetes, integrating two devices with a compatible FDA-approved integrated continuous glucose monitor (iCGM). It functions through an automated insulin dosing (AID) system powered by an adaptive closed-loop algorithm, which initially requires only the user’s body weight for configuration, removing the necessity for extra insulin dosing parameters. In contrast to conventional pump therapy, this particular system eliminates the need for manual setting adjustments, thereby easing its setup and ongoing management. Furthermore, the iLet device incorporates a meal announcement capability that streamlines mealtime insulin delivery by classifying meals into small, medium, or large categories, with the underlying algorithm progressively learning and adapting to individual insulin demands.

Which Key Players Are Driving Competition In The Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

How Does The Insulin Delivery Devices Market Perform Across Major Global Regions?

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Insulin Delivery Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2026, By The Business Research Company

Wearable Ai Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-ai-global-market-report

Smart Wearables Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-wearables-global-market-report

Wearable Computing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-computing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company